Literature DB >> 1979540

Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics.

A C Altamura1, R Cavallaro, M G Regazzetti.   

Abstract

The aim of this study was to evaluate tardive dyskinesia (TD) (prevalence and possible risk factors, pharmacological and clinical), in a population of schizophrenic patients after prolonged institutionalization. A total of 148 patients (80 male, 68 female) aged between 28 and 87 years (mean 55, SD 11) diagnosed according to DSM III were included in the study and assessed for the presence and severity of TD using the Abbreviated Rockland Simpson Scale for TD. Of the examined population, 32% were found to be affected by TD. Patients over 55 years had a relative risk of TD that was 2.3 times higher than in subjects under 55 (P less than 0.05). The most frequent movements were orofacial (60%) and in the extremities (56.4%). No significant relationship between duration of neuroleptic treatments, illness or hospitalization, anticholinergic drugs and TD prevalence was found. Severity was related to age, since there was a positive linear relationship between age and Simpson Scale scores (r = 0.45, P less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979540     DOI: 10.1007/bf02190085

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  10 in total

Review 1.  Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia.

Authors:  D E Casey; G A Keepers
Journal:  Psychopharmacol Ser       Date:  1988

Review 2.  Epidemiology of tardive dyskinesia.

Authors:  J M Kane; M Woerner; P Weinhold; B Kinon; J Lieberman; J Wegner
Journal:  Clin Neuropharmacol       Date:  1983-06       Impact factor: 1.592

Review 3.  Tardive dyskinesia.

Authors:  J Gerlach
Journal:  Dan Med Bull       Date:  1979-08

4.  The evolution of symptoms in institutionalized hebephrenic/catatonic schizophrenics.

Authors:  B Pfohl; G Winokur
Journal:  Br J Psychiatry       Date:  1982-12       Impact factor: 9.319

5.  A rating scale for tardive dyskinesia.

Authors:  G M Simpson; J H Lee; B Zoubok; G Gardos
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

6.  [Significance of trigeminal degeneration in speech disorders in hereditary ataxia].

Authors:  R STOLZE; G ULE
Journal:  Nervenarzt       Date:  1957-01-20       Impact factor: 1.214

Review 7.  Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

Authors:  J M Kane; J M Smith
Journal:  Arch Gen Psychiatry       Date:  1982-04

8.  Tardive dyskinesia: a 3-year follow-up study.

Authors:  T R Barnes; T Kidger; S M Gore
Journal:  Psychol Med       Date:  1983-02       Impact factor: 7.723

9.  Tardive dyskinesia in the aged. Duration of treatment relationships.

Authors:  L M Toenniessen; D E Casey; B H McFarland
Journal:  Arch Gen Psychiatry       Date:  1985-03

10.  Changes in prevalence, severity, and recovery in tardive dyskinesia with age.

Authors:  J M Smith; R J Baldessarini
Journal:  Arch Gen Psychiatry       Date:  1980-12
  10 in total
  3 in total

Review 1.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

2.  Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients.

Authors:  M Raja
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

3.  Neurobiological mechanisms associated with antipsychotic drug-induced dystonia.

Authors:  Anton Jm Loonen; Svetlana A Ivanova
Journal:  J Psychopharmacol       Date:  2020-09-09       Impact factor: 4.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.